Fa­tal sep­sis at­tacks blight Acor­da’s PhI­II, trig­ger­ing new safe­ty mea­sures and tor­pe­do­ing shares

Af­ter track­ing 7 cas­es of sep­sis — with 5 deaths — in stud­ies of its late-stage Parkin­son’s drug tozadenant, Acor­da is in­creas­ing pa­tient sur­veil­lance while paus­ing en­roll­ment …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER